Blue Arrow Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Blue Arrow Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-92,000	Closed	-$5.73M	–	180
2015 Q1	$5.73M	Buy	92,000 +67,000	+268%	+$3.9M	0.56%	55
2014 Q4	$1.44M	Sell	25,000 -33,000	-57%	-$1.84M	0.16%	120
2014 Q3	$3.12M	Buy	+58,000	New	+$3.07M	0.34%	95

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Blue Arrow Capital Management's TEVA Position: Q2 2015 in Review

Blue Arrow Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2015, closing a stake of 92,000 shares — an estimated $5.73M sold.

Blue Arrow Capital Management first reported a position in TEVA in Q3 2014 and held it in 3 quarters. The position peaked at $5.73M in Q1 2015. 819 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

Blue Arrow Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2015 after selling out during the quarter.
Blue Arrow Capital Management sold 92,000 Teva Pharmaceutical Industries Limited shares in Q2 2015, an estimated $5.73M.
Blue Arrow Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2014 and held it in 3 quarters.
Blue Arrow Capital Management's Teva Pharmaceutical Industries Limited position peaked at $5.73M in Q1 2015.
819 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2015.

Based on Blue Arrow Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.